A new study in rats reveals black soya beans that a diet rich in could help control weight, lower fat and cholesterol levels, and help in the prevention of diabetes. Researchers have shown that rats fed with 10 percent soya had gained half as much weight as those without. Total blood cholesterol fell by 25 percent and LDL (so-called bad) cholesterol fell by 60 percent. Preventing obesity this way may also aid diabetes prevention.
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA? (exenatide) injection.
A new study led by researchers at the McGill University Health Centre (MUHC) has identified four genes that increase the risk of developing type 2 diabetes.
Cholesterol can be a causative factor in Type 2 diabetes, revealed by scientists at Canada’s Vancouver Child and Family Research Institute.
The most important genes associated with a risk of developing type-2 diabetes have been identified, scientists report today in a new study.
While previous biomedical research studies have found that genetics and race increase risk for some diseases, a new look into how researchers study genetic triggers of type 2 diabetes suggests that defining race remains an inexact science, with social and historic facts mixing with biology throughout the research process.
A CNRS team headed by Philippe Froguel (CNRS, University of Lille 2, Pasteur Institute, Imperial College London) and Rob Sladek (McGill University, Montreal, Canada) in a French-British-Canadian collaboration that accounts for about 70 percent of the genetic risk for patients with type two diabetes.
Researchers identified five areas of DNA that could account for 70 percent of the genetic risk for type-2 diabetes.
A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes – as well as treat other health problems.